The Midbrain Dopaminergic System in Behavioral Models of Depression

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The dopaminergic system of the midbrain is involved in the pathogenesis of depression, but the nature of its involvement is illusive. The studies reviewed, devoted to behavioral models of depression, demonstrate changes in the activity of the dopaminergic system during the development of depressive-like behavior. Such changes in various target structures of dopaminergic neurons, as a rule, are multidirectional. Some of the demonstrated changes indicate the role of synaptic and/or homeostatic plasticity. At the same time, the possibilities of interpreting the results obtained in behavioral models are associated with a large number of limitations, some of which are discussed in the presented work. The most significant, in our opinion, is the need to take into account the various strategies implemented by animals in response to stress. One of the key characteristics of stressful effects that determine their impact on the organism is the ability of an individual to control these effects; it is in this regard that the results of the most valid behavioral model - the social defeat model - are ambiguous. At the same time, these problems allow us to outline important directions for further research: studying the participation of dopamine- dependent mechanisms of instrumental learning in the formation of depressive-like behavior. The steps taken in this direction already allow researchers to make therapeutically significant generalizations. Such a discourse allows us to consider depression as an experience, as was done with respect to addiction. The high comorbidity of depression and addiction, the great similarity of the depressive syndrome and hyperkathyphea in addiction, as well as the common neurophysiological substrate of both disorders allow us to assume similar mechanisms of pathological changes in these disorders at critical stages of their development.

About the authors

N. Yu. Ivlieva

Institute of Higher Nervous Activity and Neurophysiology RAS

Email: n.ivlieva@ihna.ru
Moscow, Russia

References

  1. World health organization (WHO). 2025. Depressive disorder (depression). https://www.who.int/newsroom/fact-sheets/detail/depression (date of application: September 14, 2025)
  2. Whitaker R. // Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America. New York City: Crown Publishers / Random House, 2010. 416 p.
  3. Healy D. // BMJ (Clinical research ed.). 2015. V. 350. h1771. https://doi.org/10.1136/bmj.h1771
  4. Freud S. // Über coca. Wien: M. Perles, 1885. 26 p.
  5. Shaffer H. // Subst. Abuse Treat. 1984. V. 1(3). P. 205–217.
  6. Rasmussen N. // Am. J. Public Health. 2008. V. 98(6). P. 974–985. https://doi.org/10.2105/AJPH.2007.110593
  7. Hirschfeld R.M. // J. Clin. Psychiatry. 2000. V. 61. Suppl. 6. P. 4–6.
  8. Schatzberg A.F., Cole J.O., DeBattista C. // Manual of clinical psychopharmacology, Washington, DC: American Psychiatric Publishing, 2007. 771 p.
  9. Khan A., Brown W.A. // World Psychiatry. 2015. V. 14(3). P. 294–300. https://doi.org/10.1002/wps.20241
  10. Fitzgerald P.J., Watson B.O. // Exp. Brain Res. 2019. V. 237(7). P. 1593–1614. https://doi.org/10.1007/s00221-019-05556-5
  11. Dale E., Bang-Andersen B., Sánchez C. // Biochem. Pharmacol. 2015. V. 95(2). P. 81–97. https://doi.org/10.1016/j.bcp.2015.03.011
  12. Cardona-Acosta A.M., Bolaños-Guzmán C.A. // Neuropharmacology. 2023. V. 225. 109374. https://doi.org/10.1016/j.neuropharm.2022.109374
  13. Kokane S.S., Armant R.J., Bolaños-Guzmán C.A., Perrott L.I. // Behav. Brain Res. 2020. V. 384. 112548. https://doi.org/10.1016/j.bbr.2020.112548
  14. Moncrieff J., Cooper R.E., Stockmann T., Amendola S., Hengartner M.P., Horowitz M.A. // Mol. Psychiatry. 2023. V. 28(8). P. 3243–3256. https://doi.org/10.1038/s41380-022-01661-0
  15. Moncrieff J., Cooper R.E., Stockmann T., Amendola S., Hengartner M.P., Horowitz M.A. // Mol Psychiatry. 2024. V. 29(1). P. 206–209. https://doi.org/10.1038/s41380-024-02462-3
  16. Майоров В.И. // Журн. Высш. Нервн. Деят. 2018. Т. 68. №4. С. 404–414. https://doi.org/10.1134/S0044467718040093
  17. Baik J.H. // Exp. Mol. Med. 2020. V. 52(12). P. 1879–1890. https://doi.org/10.1038/s12276-020-00532-4
  18. Lloyd K., Dayan P. // Behav. Brain Funct. 2016. V. 12(1). 15. https://doi.org/10.1186/s12993-016-0099-7
  19. Holly E.N., Miczek K.A. // Psychopharmacol. (Berl). 2016. V. 233(2). P. 163–186. https://doi.org/10.1007/s00213-015-4151-3
  20. Budygin E.A., Park J., Bass C.E., Grinevich V.P., Bonin K.D., Wightman R.M. // Neuroscience. 2012. V. 201. P. 331–337. https://doi.org/10.1016/j.neuroscience.2011.10.056
  21. Wise R.A. // Biol. Psychiatry. 2013. V. 73(9). P. 819–826. https://doi.org/10.1016/j.biopsych.2012.09.001
  22. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. // Neuron. 2010. V. 68(5). P. 815–834. https://doi.org/10.1016/j.neuron.2010.11.022
  23. Schultz W., Stauffer W.R., Lak A. // Curr. Opin. Neurobiol. 2017. V. 43. P. 139–148. https://doi.org/10.1016/j.conb.2017.03.013
  24. de Jong J.W., Afjei S.A., Pollak Dorocic I., Peck J.R., Liu C., Kim C.K., Tian L., Deisseroth K., Lammel S. // Neuron. 2019. V. 101(1). P. 133–151. e7. https://doi.org/10.1016/j.neuron.2018.11.005
  25. Morales M., Margolis E.B. // Nat. Rev. Neurosci. 2017. V. 18(2). P. 73–85. https://doi.org/10.1038/nrn.2016.165
  26. Nestler E.J., Carlezon W.A.Jr. // Biol Psychiatry. 2006. V. 59(12). P. 1151–1151. https://doi.org/10.1016/j.biopsych.2005.09.018
  27. Wang D.V., Tsien J.Z. // PLoS One. 2011. V. 6(1). e16528. https://doi.org/10.1371/journal.pone.0016528
  28. Grinevich V.P., Zakirov A.N., Berseneva U.V., Gerasimova E.V., Gainetdinov R.R., Budygin E.A. // Cells. 2022. V. 11(9). 1533. https://doi.org/10.3390/cells11091533
  29. Coddington L.T., Dudman J.T. // Neuron. 2019. V. 104(1). P. 63–77. https://doi.org/10.1016/j.neuron.2019.08.036
  30. Григорьян Г.А., Гуляева Н.В. // Журн. Высш. Нервн. Деятел. 2015. Т. 65. №6. С. 643–653. https://doi.org/10.7868/S0044467715060052
  31. Knowland D., Lim B.K. // Pharmacol. Biochem. Behav. 2018. V. 174. P. 42–52. https://doi.org/10.1016/j.pbb.2017.12.010
  32. Латанов А.В., Коршунов В.А., Майоров В.И., Серков А.Н. // Журн. высш. нервн. деятельн. им. И.П. Павлова. 2018. Т. 68. № 4. С. 413–436.
  33. Strekalova T., Liu, Y., Kiselev D., Khairuddin S., Chiu J.L.Y., Lam J., Chan Y.S., Pavlov D., Proshin A., Lesch K.P., Anthony D.C., Lim L.W. // Psychopharmacology. 2022. V. 239(3). P. 663–693. https://doi.org/10.1007/s00213-021-05982-w
  34. Tye K.M., Mirzabekov J.J., Warden M.R., Ferenczi E.A., Tsai H.C., Finkelstein J., Kim S.Y., Adhikari A., Thompson K.R., Andalman A.S., Gunaydin L.A., Witten I.B., Deisseroth K. // Nature. 2013. V. 493(7433). P. 537–541. https://doi.org/10.1038/nature11740
  35. Chang C.H., Grace A.A. // Biol. Psychiatry. 2014. V. 76(3). P. 223–230. https://doi.org/10.1016/j.biopsych.2013.09.020
  36. Zhong P., Vickstrom C.R., Liu X., Hu Y., Yu L., Yu H.G., Liu Q.S. // eLife. 2018. V. 7. e32420. https://doi.org/10.7554/eLife.32420
  37. Francis T.C., Lobo M.K. // Biological psychiatry. 2017. V. 81(8). P. 645–653. https://doi.org/10.1016/j.biopsych.2016.09.007
  38. Nagai H. // Microscopy. 2024. V. 73(5). P. 391–404. https://doi.org/10.1093/jmicro/dfae036
  39. Freund N., Thompson B.S., Sonntag K., Meda S., Andersen S.L. // Psychopharmacology (Berl). 2016. V. 233(7). P. 1191–1201. https://doi.org/10.1007/s00213-015-4200-y
  40. Anderson E.M., Gomez D., Caccamise A., McPhail D., Hearing M. // Neurobiol. Stress. 2019. V. 10. 100152. https://doi.org/10.1016/j.ynstr.2019.100152
  41. Li Y., Zhu Z.R., Ou B.C., Wang Y.Q., Tan Z.B., Deng C.M., Gao Y.Y., Tang M., So J.H., Mu Y.L., Zhang L.Q. // Behav. Brain Res. 2015. V. 279. P. 10 0 – 10 5 . https://doi.org/10.1016/j.bbr.2014.11.016
  42. Kudryavtseva N.N., Bakshtanovskaya I.V., Koryakina L.A. // Pharmacol. Biochem. Behav. 1991. V. 38. P. 315–320. https://doi.org/10.1016/0091-3057(91)90284-9
  43. Golden S.A., Covington H.E., 3rd, Berton O., Russo S.J. // Nature protocols. 2011. V. 6(8). P. 1183–1191. https://doi.org/10.1038/nprot.2011.361
  44. Krishnan V., Han M. H., Graham D.L. et al. //Cell. 2007. V. 131(2). P. 391–404. https://doi.org/10.1016/j.cell.2007.09.018
  45. Cao J.L., Covington H.E., 3rd, Friedman A.K., Wilkinson M.B., Walsh J.J., Cooper D.C., Nestler E.J., Han M.H. // J. Neurosci. 2010. V. 30(49). P. 16453–16458. https://doi.org/10.1523/JNEUROSCI.3177-10.2010
  46. Chaudhury D., Walsh J.J., Friedman A.K. et al. // Nature. 2013. V. 493(7433). P. 532–536. https://doi.org/10.1038/nature11713
  47. Friedman A.K., Walsh J.J., Juarez B., Ku S.M., Chaudhury D., Wang J., Li X., Dietz D.M., Pan N., Vialou V.F., Neve R.L., Yue Z., Han M.H. // Science. 2014. V. 344(6181). P. 313–319. https://doi.org/10.1126/science.1249240
  48. Knowland D., Lilascharoen V., Pacia C.P., Shin S., Wang E.H., Lim B.K. // Cell. 2017. V. 170(2). P. 284–297. e18. https://doi.org/10.1016/j.cell.2017.06.015
  49. Morel C., Montgomery S.E., Li L., Durand-de Cuttoli R., Teichman E.M., Juarez B., Tzavaras N., Ku S. M., Flanigan M.E., Cai M., Walsh J.J., Russo S.J., Nestler E.J., Calipari E.S., Friedman A.K., Han M.H. // Nature communications. 2022. V. 13(1). 1532. https://doi.org/10.1038/s41467-022-29155-1
  50. Willmore L., Cameron C., Yang J., Witten I.B., Falkner A.L. // Nature. 2022. V. 611(7934). P. 124–132. https://doi.org/10.1038/s41586-022-05328-2
  51. Quessy F., Bittar T., Blanchette L.J., Lévesque M., Labonté B. // Scientific reports. 2021. V. 11(1). 11000. https://doi.org/10.1038/s41598-021-90521-y
  52. Belujon P., Grace A.A. // Biol. Psychiatry. 2014. V. 76(12). P. 927–936. https://doi.org/10.1016/j.biopsych.2014.04.014
  53. Wu M., Minkowicz S., Dumrongprechachan V., Hamilton P., Xiao L., Kozorovitskiy Y. // eLife. 2021. V. 10. e64041. https://doi.org/10.7554/eLife.64041
  54. Parise E.M., Parise L.F., Sial O.K., CardonaAcosta A.M., Gyles T.M., Juarez B., Chaudhury D., Han M. H., Nestler E.J., Bolaños-Guzmán C.A. // Biol. Psychiatry. 2021. V. 90(7). P. 482–493. https://doi.org/10.1016/j.biopsych.2021.05.002
  55. Hammen C. // J. Abnorm. Psychol. 1991. V. 100(4). P. 555–561. https://doi.org/10.1037//0021-843x.100.4.555
  56. Hammen C. // J. clinical psychol. 2006. V. 62(9). P. 1065–1082. https://doi.org/10.1002/jclp.20293
  57. Liu R.T., Alloy L.B. // Clin. Psychol. Rev. 2010. V. 30(5). P. 582–593. https://doi.org/10.1016/j.cpr.2010.04.010
  58. Robinson E.S.J. // Philos. Trans. R. Soc. Lond. B Biol. Sci. 2018. V. 373(1742). 20170036. https://doi.org/10.1098/rstb.2017.0036
  59. Hoppmann U., Engler H., Krause S., Rottler E., Hoech J., Szabo F., Radermacher P., Waller C. // J. Clin. Med. 2021. V. 10(5). 986. https://doi.org/10.3390/jcm10050986
  60. Lechin F., Van der Dijs B., Benaim M. //Prog. Neuropsychopharmacol. Biol. Psychiatry. 1996. V. 20(6). P. 899–950. https://doi.org/10.1016/0278-5846(96)00075-9
  61. Селье Г. // Стресс без дистресса. М.: Прогресс, 1979. 80 c.
  62. Hagen E.H. // Can. J. Psychiatry. 2011. V. 56(12). P. 716–726. https://doi.org/10.1177/07067437110560120
  63. Hendrie C.A., Pickles A.R. // Medical hypotheses. 2009. V. 72(3). P. 342–347. https://doi.org/10.1016/j.mehy.2008.09.053
  64. Seligman M.E., Maier S.F. // J. Exp. Psychol. 1967. V. 74(1). P. 1–9. https://doi.org/10.1037/h0024514
  65. Maier S.F., Seligman M.E. // Psychol. Review. 2016. V. 123(4). P. 349–367. https://doi.org/10.1037/rev0000033
  66. Amat J., Christianson J.P., Aleksejev R.M., Kim J., Richeson K.R., Watkins L.R., Maier S.F. // Eur. J. Neurosci. 2014. V. 40(2). P. 2352–2358. https://doi.org/10.1111/ejn.12609
  67. McNulty C.J., Fallon I.P., Amat J., Sanchez R.J., Leslie N.R., Root D.H., Maier S.F., Baratta M.V. // Neuropsychopharmacology. 2023. V. 48(3). P. 498–507. https://doi.org/10.1038/s41386-022-01443-w
  68. Baratta M.V., Leslie N.R., Fallon I.P. et al. // Eur. J. Neurosci. 2018. V. 47. P. 959–967. https://doi.org/10.1111/ejn.13833
  69. Balleine B.W., Dezfouli A. // Front. Psychol. 2019. V. 10. 2735. https://doi.org/10.3389/fpsyg.2019.02735
  70. Hartogsveld B., van Ruitenbeek P., Quaedflieg C.W.E.M., Smeets T. // Exp Psychol. 2020. V. 67. P. 99–111. https://doi.org/10.1027/1618-3169/a000485
  71. Хаслер Ф. // Нейромифология. Что мы действительно знаем о мозге и чего мы не знаем о нем, М.: Издательство АСТ, 2023. 382 c.
  72. Хан Б.-Ч. // Общество усталости. Негативный опыт в эпоху чрезмерного позитива, М.: Издательство АСТ, 2023. 160 c.
  73. Carey T.L. // Handb. Exp. Pharmacol. 2019. V. 250. P. 359–370. https://doi.org/10.1007/164_2018_162
  74. Xu L., Nan J., Lan Y. // Front. Neural Circuits. 2020. 14. 37. https://doi.org/10.3389/fncir.2020.00037
  75. Fox M.E., Lobo M.K. // Mol. Psychiatry. 2019. V. 24(12). P. 1798–1815. https://doi.org/10.1038/s41380-019-0415-3
  76. Kokane S.S., Armant R.J., Bolaños-Guzmán C.A., Perrotti L.I. // Behav. Brain Res. 2020. V. 384. 112548. https://doi.org/10.1016/j.bbr.2020.112548
  77. Rasmussen K.G. // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2016. V. 64. P. 218–224. https://doi.org/10.1016/j.pnpbp.2015.01.002
  78. Koob G.F. // Development. Pharmacol. Rev. 2021. V. 73(1). P. 163–201. https://doi.org/10.1124/pharmrev.120.000083
  79. Gentry R.N., Schuweiler D.R., Roesch M.R. // Brain Res. 2019. V. 1713. P. 80–90. https://doi.org/10.1016/j.brainres.2018.10.008
  80. Giovanniello J.R., Paredes N., Wiener A. et al. // Nature. 2025. V. 640(8059). P. 722–731. https://doi.org/10.1038/s41586-024-08580-w
  81. Burnette E.M., Grodin E.N., Schacht J.P., Ray L.A. // Alcohol. Clin. Exp. Res. 2021. V. 45(1). P. 194–203. https://doi.org/10.1111/acer.14495
  82. Wang J., Wang S. // Behav Sci (Basel). 2025. V. 15(5). 665. https://doi.org/10.3390/bs15050665
  83. Huston J.P., Silva M.A., Komorowski M., Schulz D. // Topic B. Neurosci Biobehav Rev. 2013. V. 37(9 Pt A). P. 2059–2070. https://doi.org/10.1016/j.neubiorev.2013.02.016
  84. Piazza P.V., Deroche–Gamonet V. // Psychopharmacology (Berl). 2013. V. 229(3). P. 387–413. https://doi.org/10.1007/s00213-013-3224-4
  85. Соломон Э. // Демон полуденный. Анатомия депрессии. М.: Добрая книга, 2004. 672 c.
  86. de Leon J., Baca-García E., Blasco-Fontecilla H. // Psychother. Psychosom. 2015. V. 84(6). P. 323–329. https://doi.org/10.1159/000438510
  87. Левинас Э. // Избранное: Тотальность и бесконечное. М.–СПб.: Центр гуманитарных инициатив, 2024. 372 c.
  88. Post R.J., Warden M.R. // Curr. Opin. Neurobiol. 2018. V. 49. P. 192–200. https://doi.org/10.1016/j.conb.2018.02.018
  89. Fried E.I., Flake J.K., Robinaugh D.J. // Nat. Rev. Psychol. 2022. V. 1(6). P. 358–368. https://doi.org/10.1038/s44159-022-00050-2
  90. Baratta M.V., Seligman M.E.P., Maier S.F. // Front. Psychiatry. 2023. V. 14. 1170417. https://doi.org/10.3389/fpsyt.2023.1170417

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Russian Academy of Sciences

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).